AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Precipio, Inc.

$27.32 +$3.50 (+14.69%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$26.91
Day Range
$26.25$27.93
Year Range
$16$33.63
Market Cap
48.73M
AVG Volume
89.9K
Trailing/Forward PE
-42.03/1
PEG ratio
-0.63
Dividend Yield
-
Next Earnings Date
2026-11-16
Primary Exchange
NASDAQUS
Revenue (USD)
010M20M30M2016201720182019202020212022202320242025
PRPO Revenue (USD) by year
PeriodRevenue (USD)
202524.05M
202418.53M
202314.42M
20229.41M
20218.85M
20206.09M
20193.13M
20182.86M
20172.13M
20161.56M
Net Income (USD)
-30M-20M-10M02016201720182019202020212022202320242025
PRPO Net Income (USD) by year
PeriodNet Income (USD)
2025-363K
2024-4.29M
2023-5.85M
2022-12.2M
2021-8.53M
2020-10.62M
2019-13.24M
2018-15.69M
2017-21.7M
2016-7.62M
Operating Income (USD)
-20M-15M-10M-5M02016201720182019202020212022202320242025
PRPO Operating Income (USD) by year
PeriodOperating Income (USD)
2025-1.2M
2024-4.22M
2023-7.62M
2022-12.8M
2021-9.61M
2020-9.15M
2019-10.99M
2018-13.91M
2017-16.47M
2016-7.82M
EBITDA (USD)
-15M-10M-5M05M2016201720182019202020212022202320242025
PRPO EBITDA (USD) by year
PeriodEBITDA (USD)
20251.39M
2024-2.72M
2023-4.37M
2022-10.69M
2021-7.11M
2020-8.13M
2019-8.05M
2018-7.96M
2017-5.45M
2016-4.5M
Cash Flows (USD)
-10M-7.5M-5M-2.5M02.5M2016201720182019202020212022202320242025
PRPO Cash Flows (USD) by year
PeriodCash Flows (USD)
2025359K
2024216K
2023-3.69M
2022-8M
2021-7.22M
2020-7.58M
2019-9.2M
2018-6.85M
2017-6.83M
2016-3.57M
EPS (USD)
-3000-2000-100002016201720182019202020212022202320242025
PRPO EPS (USD) by year
PeriodEPS (USD)
2025-0.26
2024-2.96
2023-4.88
2022-10.23
2021-8.07
2020-16.99
2019-46.77
2018-215.01
2017-967.34
2016-2207.71
Expenses (USD)
05M10M15MR&DSG&ACapex2016201720182019202020212022202320242025
PRPO Expenses (USD) by year
PeriodExpenses (USD)
2025326K
202411.13M
202312.69M
202211.03M
20218.87M
202012.65M
201912.47M
201810.65M
20177.59M
20167.63M
Cash & Debt (USD)
05M10M15MCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
PRPO Cash & Debt (USD) by year
PeriodCash & Debt (USD)
20256.04M
20241.39M
20231.5M
20223.44M
202111.67M
20202.66M
2019848K
2018381K
2017421K
2016110K
Debt ratios
-0.200.20.420182019202020212022202320242025
PRPO Debt ratios by year
PeriodDebt ratios
20250.15
20240.01
20230.01
20220.06
20210.33
20200.04
2019-0.02
2018-0.18
Margins
-20%0%20%40%60%2016201720182019202020212022202320242025
PRPO Margins by year
PeriodMargins
202544.52%
202439.19%
202341.74%
202222.61%
202124%
202018.88%
20197%
20187.86%
201719.92%
2016-13.17%
Return on Capital
-300%-200%-100%0%100%2016201720182019202020212022202320242025
PRPO Return on Capital by year
PeriodReturn on Capital
2025-2.49%
2024-35.47%
2023-40.56%
2022-74.56%
2021-34.67%
2020-75.02%
2019-100.29%
2018-256.31%
2017-166.58%
201639.36%
Shares Outstanding
0500K1M1.5M2M2016201720182019202020212022202320242025
PRPO Shares Outstanding by year
PeriodShares Outstanding
20251.61M
20241.49M
20231.42M
20221.14M
20211.14M
2020878.85K
2019394.9K
201898.81K
201733.99K
20162.86K
Book Value Per Share (USD)
-8000-6000-4000-2000020002016201720182019202020212022202320242025
PRPO Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
20259.07
20248.1
202310.16
202214.34
202121.67
202016.11
201933.44
201861.97
2017383.22
2016-6770.47
Total Assets (USD)
010M20M30M40M2016201720182019202020212022202320242025
PRPO Total Assets (USD) by year
PeriodTotal Assets (USD)
202521.32M
202417M
202318.1M
202221.5M
202130.44M
202020.71M
201919.51M
201821.61M
201727.26M
20161.26M
Employee Count
0204060802013201720182019202020212022202320242025
PRPO Employee Count by year
PeriodEmployee Count
202561
202454
202351
202253
202155
202054
201950
201842
201731
20135
Free Cash Flow Yield
-15%-10%-5%0%5%10%med 1.46%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
PRPO Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 261.62%
Sep 261.61%
Aug 261.53%
Aug 261.45%
Aug 261.88%
Aug 261.3%
Jul 261.44%
Jul 261.31%
Jul 261.26%
Jul 261.31%
Jul 261.23%
Jun 261.34%
Jun 261.39%
Jun 261.41%
Jun 261.33%
May 261.37%
May 261.31%
May 261.2%
May 260.75%
May 260.72%
Apr 260.8%
Apr 260.79%
Apr 260.82%
Apr 260.88%
Mar 261.39%
Mar 261.29%
Mar 261.34%
Mar 261.36%
Feb 261.49%
Feb 261.42%
Feb 261.54%
Feb 261.79%
Jan 261.47%
Jan 261.47%
Jan 261.53%
Jan 261.45%
Jan 261.51%
Dec 251.51%
Dec 251.62%
Dec 251.44%
Dec 251.5%
Nov 251.48%
Nov 251.47%
Nov 251.86%
Nov 251.87%
Oct 251.82%
Oct 251.82%
Oct 252.16%
Oct 251.96%
Oct 251.8%
Sep 252.14%
Sep 252.24%
Sep 251.91%
Sep 252.1%
Aug 252.4%
Aug 252.62%
Aug 252.54%
Aug 253.36%
Aug 253.23%
Jul 253.17%
Jul 253.22%
Jul 252.99%
Jul 253.87%
Jun 254.29%
Jun 254.13%
Jun 254.3%
Jun 254.17%
May 254.94%
May 254.82%
May 255.92%
May 252.18%
May 251.98%
Apr 252.4%
Apr 252.46%
Apr 252.56%
Apr 252.74%
Mar 252.31%
Mar 25-2.39%
Mar 25-2.26%
Mar 25-2.34%
Feb 25-2.23%
Feb 25-1.6%
Feb 25-2.25%
Feb 25-2.44%
Jan 25-2.36%
Jan 25-2.48%
Jan 25-2.49%
Jan 25-2.64%
Jan 25-2.92%
Dec 24-2.94%
Dec 24-3.08%
Dec 24-2.79%
Dec 24-2.8%
Nov 24-2.73%
Nov 24-2.74%
Nov 24-2.62%
Nov 24-2.66%
Nov 24-11.83%
Oct 24-11.8%
Oct 24-11.56%
Price to Sales
00.511.522.5med 1.35Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
PRPO Price to Sales by year
PeriodPrice to Sales
Sep 261.78
Sep 261.78
Aug 261.88
Aug 261.98
Aug 261.53
Aug 261.64
Jul 261.48
Jul 261.62
Jul 261.68
Jul 261.63
Jul 261.73
Jun 261.59
Jun 261.53
Jun 261.51
Jun 261.61
May 261.56
May 261.63
May 261.78
May 261.99
May 262.06
Apr 261.87
Apr 261.89
Apr 261.82
Apr 261.7
Mar 261.98
Mar 262.12
Mar 262.04
Mar 262.02
Feb 261.83
Feb 261.93
Feb 261.78
Feb 261.53
Jan 261.87
Jan 261.87
Jan 261.79
Jan 261.88
Jan 261.81
Dec 251.81
Dec 251.69
Dec 251.9
Dec 251.83
Nov 251.85
Nov 251.86
Nov 251.47
Nov 251.47
Oct 251.51
Oct 251.51
Oct 251.27
Oct 251.4
Oct 251.53
Sep 251.28
Sep 251.23
Sep 251.44
Sep 251.31
Aug 251.14
Aug 251.05
Aug 251.08
Aug 251.08
Aug 251.12
Jul 251.14
Jul 251.13
Jul 251.21
Jul 250.94
Jun 250.84
Jun 250.88
Jun 250.84
Jun 250.87
May 250.73
May 250.75
May 250.61
May 250.53
May 250.59
Apr 250.49
Apr 250.47
Apr 250.46
Apr 250.42
Mar 250.51
Mar 250.58
Mar 250.61
Mar 250.59
Feb 250.62
Feb 250.86
Feb 250.61
Feb 250.57
Jan 250.58
Jan 250.56
Jan 250.55
Jan 250.52
Jan 250.47
Dec 240.47
Dec 240.45
Dec 240.49
Dec 240.49
Nov 240.5
Nov 240.5
Nov 240.53
Nov 240.52
Nov 240.58
Oct 240.58
Oct 240.59
EV/EBITDA
050100150200250med 106.27Nov 25Jan 26Feb 26Apr 26Jun 26Jul 26Sep 26
PRPO EV/EBITDA by year
PeriodEV/EBITDA
Sep 26199.55
Sep 26200.13
Aug 26210.67
Aug 26222.29
Aug 26171.8
Aug 2650.73
Jul 2645.92
Jul 2650.13
Jul 2652.12
Jul 2650.38
Jul 2653.41
Jun 2649.36
Jun 2647.58
Jun 2646.85
Jun 2649.74
May 2648.3
May 2650.38
May 2655.02
May 2632.73
May 2634.04
Apr 2630.64
Apr 2630.98
Apr 2629.77
Apr 2627.63
Mar 26120.61
Mar 26129.23
Mar 26124.63
Mar 26123.14
Feb 26112.09
Feb 26117.86
Feb 26108.97
Feb 2693.95
Jan 26114.16
Jan 26114.21
Jan 26109.47
Jan 26115.2
Jan 26110.91
Dec 25110.64
Dec 25103.56
Dec 25116.1
Dec 25111.82
Nov 25113.21
Nov 25113.98
Nov 2590.66
Price/Operating Cashflow
020406080med 43.53Jun 25Aug 25Nov 25Jan 26Apr 26Jun 26Sep 26
PRPO Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Sep 2644.39
Sep 2644.52
Aug 2646.88
Aug 2649.48
Aug 2638.18
Aug 2653.9
Jul 2648.68
Jul 2653.25
Jul 2655.4
Jul 2653.51
Jul 2656.8
Jun 2652.41
Jun 2650.48
Jun 2649.69
Jun 2652.82
May 2651.27
May 2653.51
May 2658.55
May 2669.85
May 2672.5
Apr 2665.61
Apr 2666.31
Apr 2663.85
Apr 2659.52
Mar 2648.11
Mar 2651.64
Mar 2649.75
Mar 2649.14
Feb 2644.6
Feb 2646.98
Feb 2643.33
Feb 2637.16
Jan 2645.46
Jan 2645.48
Jan 2643.53
Jan 2645.88
Jan 2644.12
Dec 2544.01
Dec 2541.1
Dec 2546.25
Dec 2544.49
Nov 2545.07
Nov 2545.38
Nov 2535.81
Nov 2533.1
Oct 2533.93
Oct 2534.01
Oct 2528.55
Oct 2531.51
Oct 2534.39
Sep 2528.83
Sep 2527.62
Sep 2532.28
Sep 2529.36
Aug 2525.69
Aug 2523.6
Aug 2524.33
Aug 2519.67
Aug 2520.46
Jul 2520.8
Jul 2520.53
Jul 2522.04
Jul 2517.05
Jun 2515.38
Jun 2515.99
Jun 2515.35
Jun 2515.85
May 2513.36
May 2513.7
May 2511.15
May 2522.56
May 2524.91
Apr 2520.52
Apr 2520.01
Apr 2519.26
Apr 2517.93
Mar 2521.33
Price to Book
01234med 2.24Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
PRPO Price to Book by year
PeriodPrice to Book
Sep 263.31
Sep 263.32
Aug 263.49
Aug 263.69
Aug 262.85
Aug 263.02
Jul 262.72
Jul 262.98
Jul 263.1
Jul 263
Jul 263.18
Jun 262.93
Jun 262.83
Jun 262.78
Jun 262.96
May 262.87
May 263
May 263.28
May 263.29
May 263.41
Apr 263.09
Apr 263.12
Apr 263
Apr 262.8
Mar 263.09
Mar 263.32
Mar 263.2
Mar 263.16
Feb 262.87
Feb 263.02
Feb 262.79
Feb 262.39
Jan 262.92
Jan 262.92
Jan 262.8
Jan 262.95
Jan 262.84
Dec 252.83
Dec 252.64
Dec 252.97
Dec 252.86
Nov 252.9
Nov 252.92
Nov 252.3
Nov 252.46
Oct 252.53
Oct 252.53
Oct 252.13
Oct 252.35
Oct 252.56
Sep 252.15
Sep 252.06
Sep 252.4
Sep 252.19
Aug 251.91
Aug 251.76
Aug 251.81
Aug 251.79
Aug 251.86
Jul 251.89
Jul 251.86
Jul 252
Jul 251.55
Jun 251.4
Jun 251.45
Jun 251.39
Jun 251.44
May 251.21
May 251.24
May 251.01
May 250.82
May 250.9
Apr 250.74
Apr 250.73
Apr 250.7
Apr 250.65
Mar 250.77
Mar 250.84
Mar 250.89
Mar 250.86
Feb 250.9
Feb 251.26
Feb 250.89
Feb 250.82
Jan 250.85
Jan 250.81
Jan 250.81
Jan 250.76
Jan 250.69
Dec 240.68
Dec 240.65
Dec 240.72
Dec 240.72
Nov 240.74
Nov 240.73
Nov 240.77
Nov 240.76
Nov 240.76
Oct 240.76
Oct 240.78
Precipio, Inc.
PRPO
Stockpicker

Video analysis: PRPO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: PRPO

PRPO vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now?

zacks.com · 24 Aug 2026

PRPO vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now?

Precipio and Biodesix take different approaches to cancer diagnostics, but which stock looks more compelling now? Let's dive in.

Precipio Stock Gains Post Q2 Earnings, Revenue Momentum Strong

zacks.com · 21 Aug 2026

Precipio Stock Gains Post Q2 Earnings, Revenue Momentum Strong

PRPO's second-quarter 2026 revenue momentum strengthens on higher diagnostic volumes and record product sales, alongside positive adjusted EBITDA and cash generation.

Precipio, Inc. (PRPO) Q2 2026 Earnings Call Transcript

seekingalpha.com · 17 Aug 2026

Precipio, Inc. (PRPO) Q2 2026 Earnings Call Transcript

Precipio, Inc. (PRPO) Q2 2026 Earnings Call Transcript

Precipio Announces Q2-2026 Financial Results

globenewswire.com · 14 Aug 2026

Precipio Announces Q2-2026 Financial Results

Revenue reaches quarterly record as Precipio returns to positive Adjusted EBITDA and strengthens cash position Revenue reaches quarterly record as Precipio returns to positive Adjusted EBITDA and strengthens cash position

Precipio (NASDAQ:PRPO) Stock Price Passes Below Two Hundred Day Moving Average   – Should You Sell?

defenseworld.net · 1 Aug 2026

Precipio (NASDAQ:PRPO) Stock Price Passes Below Two Hundred Day Moving Average – Should You Sell?

Precipio, Inc. (NASDAQ: PRPO - Get Free Report) passed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $25.12 and traded as low as $20.20. Precipio shares last traded at $21.65, with a volume of 21,130 shares trading hands. Analysts Set New Price Targets A number of

Precipio Announces Q2-2026 Shareholder Update Call

globenewswire.com · 31 Jul 2026

Precipio Announces Q2-2026 Shareholder Update Call

NEW HAVEN, Conn., July 31, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc.   (NASDAQ: PRPO) , will be hosting its Q2-2026 shareholder update call on August 17th, 2026, at 5:00 PM ET.

PRPO vs. NEO: Which Cancer Diagnostics Stock Is the Better Buy?

zacks.com · 16 Jul 2026

PRPO vs. NEO: Which Cancer Diagnostics Stock Is the Better Buy?

Precipio and NeoGenomics take different approaches to cancer diagnostics, but which oncology stock looks more compelling now? Let's dive in.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.